Mangoceuticals, Inc.

The momentum for this stock is not very good. Mangoceuticals, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Mangoceuticals, Inc..
Log in to see more information.
MGRX Fundamental Data by TradingView

News

Mangoceuticals files 16.17M shares of common stock for holders
Mangoceuticals files 16.17M shares of common stock for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024
MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nMangoceuticals just reported results for the second quarter of 2024.\nThe post MGRX Stock Earnings: Mangoceuticals Reported Results for...\n more…

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

Globe Newswire Dallas, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ( MangoRx or the Company ), a company focused on developing, marketing, and selling a variety of men's health...\n more…

Mangoceuticals receives patent in India, initiates clinical trials
Mangoceuticals receives patent in India, initiates clinical trials

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent
MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

Globe Newswire Dallas, Texas, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ( MangoRx or the Company ), a company focused on developing, marketing, and selling a variety of men's health...\n more…

Mangoceuticals completes migration to DEA-approved telemedicine platform
Mangoceuticals completes migration to DEA-approved telemedicine platform

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…